Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment
John D. Klement, Priscilla S. Redd, Chunwan Lu, et al.
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 620-636.e9
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Targeting innate immune pathways for cancer immunotherapy
Longyue L. Cao, Jonathan C. Kagan
Immunity (2023) Vol. 56, Iss. 10, pp. 2206-2217
Open Access | Times Cited: 87
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 85
Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy
Xufeng Lu, Xiaohong Chen, Chengyin Lin, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 65
Type I interferon and cancer
Peter Holíček, Emma Guilbaud, Vanessa Klapp, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 115-127
Open Access | Times Cited: 45
The B7:CD28 family and friends: Unraveling coinhibitory interactions
Kelly P. Burke, Apoorvi Chaudhri, Gordon J. Freeman, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 223-244
Open Access | Times Cited: 34
T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution
Wenhui Yang, Shimao Liu, Mengyun Mao, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 27
Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade
Bridget M. Fortin, Shannon M. Pfeiffer, Jacob Insua‐Rodríguez, et al.
Nature Immunology (2024) Vol. 25, Iss. 7, pp. 1257-1269
Open Access | Times Cited: 22
Parps in immune response: Potential targets for cancer immunotherapy
S Wang, Jingling Huang, T. X. Zeng, et al.
Biochemical Pharmacology (2025) Vol. 234, pp. 116803-116803
Closed Access | Times Cited: 3
Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy
Huan Song, Lin Chen, Xuanxuan Pan, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 503-518.e10
Open Access | Times Cited: 2
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer
Jie Xia, Lixing Zhang, Xilei Peng, et al.
Cancer Research (2024) Vol. 84, Iss. 14, pp. 2282-2296
Closed Access | Times Cited: 17
Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment
Die Lv, Yujie Fei, Hongli Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
The complexity of immune evasion mechanisms throughout the metastatic cascade
Nicole M. Haynes, Thomas B Chadwick, Belinda S. Parker
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1793-1808
Closed Access | Times Cited: 12
Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade
Julia Holzgruber, Christina Martins, Zsófi Kulcsár, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Mn(II) Optimized Sono/Chemodynamic Effect of Porphyrin‐Metal–Organic Framework Nanosheets for MRI‐Guided Colon Cancer Therapy and Metastasis Suppression
Lifeng Hang, Meng Li, Yuxuan Zhang, et al.
Small (2023) Vol. 20, Iss. 15
Closed Access | Times Cited: 22
Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination
Zhijia Sun, Haixing Mai, Chunyuan Xue, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e007415-e007415
Open Access | Times Cited: 19
CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1–positive regulator for tumor immune evasion
Shengnan Wang, Radhika Iyer, Xiaohua Han, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 23
Open Access | Times Cited: 17
Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma
Weidong Chen, Yan Liao, Pengxiao Sun, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Unravelling immune microenvironment features underlying tumor progression in the single-cell era
Qilian Du, Qi An, Jiajun Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME
Vijay Kumar, Caitlin Bauer, John H. Stewart
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 16
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma
Shengqiang Mao, Yilong Wang, Ningning Chao, et al.
Cellular Oncology (2024) Vol. 47, Iss. 5, pp. 1697-1713
Closed Access | Times Cited: 6
In vivo single-cell high-dimensional mass cytometry analysis to track the interactions between Klebsiella pneumoniae and myeloid cells
Ricardo Calderón-González, Amy Dumigan, Joana Sá‐Pessoa, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 4, pp. e1011900-e1011900
Open Access | Times Cited: 5
A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma
Xinyu Guo, Tianming Cui, Linmao Sun, et al.
Cell Death and Differentiation (2024)
Closed Access | Times Cited: 5
Immune landscape and response to oncolytic virus-based immunotherapy
Chaolong Lin, Wenzhong Teng, Tian Yang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 411-429
Closed Access | Times Cited: 5
PD-L2 drives resistance to EGFR-TKIs: dynamic changes of the tumor immune environment and targeted therapy
Simeng Wang, Dongliang Su, Han Chen, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 9, pp. 1140-1156
Closed Access | Times Cited: 5
AI-Enhanced Blood Cell Recognition and Analysis: Advancing Traditional Microscopy with the Web-Based Platform IKOSA
Manuel Campos-Medina, A. Blumer, Patrick Kraus-Füreder, et al.
Journal of Molecular Pathology (2024) Vol. 5, Iss. 1, pp. 28-44
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top